Stay up-to-date on the latest (Belgium) Oncology News!
On February 19, 2016, the U.S. Food and Drug Administration approved palbociclib (Ibrance) in combination with fulvestrant for the treatment …
FDA expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage …
ESMO launched new guidelines on management of oral and gastrointestinal mucosal injury. ESMO guidelines are available at:http://annonc.oxfordjournals.org/content/early/2015/07/04/annonc.mdv202.long News overview
On 1 july 2015, Stivarga® (regorafenib) is reimbursed in Belgium. Stivarga® is an oral drug that can be prescribed for the treatment …
Le KCE a publié ce matin un nouveau guide de pratique clinique pour le diagnostic et le traitement du …
Het KCE publiceerde vanmorgen een nieuwe guideline over de diagnose en behandeling van kanker van de urineblaas. U kan het …
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European …
On April 25, 2016, the U. S. Food and Drug Administration approved cabozantinib (CABOMETYX, Exelixis, Inc.) for the treatment of …
FDA Approves Venetoclax for Chronic Lymphocytic Leukemia With 17p Deletion www.fda.gov/newsevents/newsroom/pressannouncements/ucm495253.htm News overview
FDA approves new drug treatment for nausea and vomiting from chemotherapy More informationNews overview
Perjeta recommended for approval in EU for use before surgery in HER2-positive early breast cancer The Perjeta regimen is the …
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer …